HRTX
Heron Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.34
+4.21%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.86x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 9.45x
- Price / sales
- 0.43x
- Price / cash flow
- -5.63x
Enterprise value
- Enterprise value
- $172.0M
- EV / sales
- 1.14x
- EV / EBITDA
- -6.18x
- EV / EBIT
- -15.83x
- Market cap
- $65.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026